CYAD
Celyad Oncology SA American Depositary Shares
CYAD
CYAD
Delisted
CYAD was delisted on the 18th of May, 2023.
8 hedge funds and large institutions have $13.7M invested in Celyad Oncology SA American Depositary Shares in 2018 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
8
Holders Change
-4
Holders Change %
-33.33%
% of All Funds
0.18%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
4
Reduced
1
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
Millennium Management
New York
|
+$675K |
2 |
Victory Capital Management
San Antonio,
Texas
|
+$457K |
3 |
Morgan Stanley
New York
|
+$67.5K |
4 |
Wells Fargo
San Francisco,
California
|
+$3.25K |
5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2K |